CRO eNewsletter August 2008
This is Applied Clinical Trials' enewsletter, CRO News, which provides a forum for the industry to discuss the latest alliances, financial information, and business deals and developments, as well as people news.
Outsourcing's Hottest Trends
The August issue of Applied Clinical Trials ended summer with articles about the hottest trends in Outsourcing. The articles related to CROs and Outsourcing include: How We Fail to Use CROs Effectively (And What You Can Do About It); Steps to Functional Service Provider Success; and Outsourcing's Evolution from Commodity to Partner.
>>
The Dawning of a New Era
DataLabs by ClinPhone is the only true hybrid system, incorporating EDC and Paper Data Management in a single platform. Learn more:
Sue Price and Pedro Pala
have both become new members of the team at Penn Pharmaceutical Services. Sue Price will act as head of clinical trial supplies and Pedro Pala will serve as CTS project manager.
>>
Ronald Kershner
has been appointed by AAIPharma to lead the North American Biostatistics and Data Management Services groups. Kershner brings with him more than 25 years of experience in the industry, including with regulatory submissions and FDA interactions.
>>
Patrice Hugo
will be the new vice president of scientific affairs at MDS Pharma Services' global central lab network, where he will lead the development of biomarkers from Phases I through IV.
>>
Christopher H. Cabell
is the new chief medical and scientific officer for Quintiles Transnational Corp. In this position Cabell will be responsible for company initiatives focusing on bioethics and the protection of human subjects.
>>
Kenneth G. Faulkner
will take the position of vice president of medical imaging at Perceptive Informatics, a division of Parexel International. Dr. Faulkner brings with him 22 years of experience in medical imaging.
>>
October 22-23, 2008
Doubletree Guest Suites| Lake Buena Vista, FL
October 12-15, 2008
Venetian Congress Center and Palazzo Hotel| Las Vegas, NV
November 13 , 2008
Washington, DC
While Covance acquired some of Lilly's drug development business (see left), the pharmaceutical company also transferred its U.S. and Puerto Rico-based clinical trial monitoring work to
For CROs still using static databases for site selection, Health Market Science is offering its Clinical Investigators online tool to increase insight into the potential patient pool. Read the release
You are subscribed to %%list.name%% as %%emailaddr%%. To unsubscribe from this list
Advanstar Communications provides certain customer contact data (such as customers' names, addresses, phone numbers and e-mail addresses) to third parties who wish to promote relevant products, services and other opportunities which may be of interest to you. If you do not want Advanstar Communications to make your contact information available to third parties for marketing purposes, simply call (toll free) 1-866-529-2922 at any time, or fax us at 1-218-740-6417. Outside the U.S., please phone 1-218-740-6395. Contact us by mail at Advanstar Communications Inc., 131 West First St., Duluth, MN 55802-2065, USA.
Newsletter
Stay current in clinical research with Applied Clinical Trials, providing expert insights, regulatory updates, and practical strategies for successful clinical trial design and execution.
Related Articles
- NIMBLE Trial Reveals New Insights on Complement Inhibition in gMG
September 15th 2025
- Q&A: Strategies for Successful Global Clinical Trial Delivery
September 12th 2025